Evaluation of four commercial COVID-19 diagnostic RT-PCR kits used in Libya

Authors

  • Khadija M. Ahmad
  • Shamsi S Shamsi
  • Mohammed B Alsubbi
  • Ali A. Aldalouli
  • Hamad A Almahdi
  • Alkeelani M M Alkeelani
  • Ibrahim A. Mohamed

DOI:

https://doi.org/10.51984/joms.v18i1.2600

Keywords:

Real-time PCR, COVID-19, molecular technique, respiratory infection, diagnostic kits

Abstract

Background: Real-time reverse transcriptase chain reaction is considered the most sensitive and specific assay for COVID-19 detection. This study was planned to compare and evaluate four commercially diagnostic kits. Material and methods: 92 Nasopharyngeal swabs collected from different symptomatic patients were studied in this project. The total nucleic acid (RNA) was extracted, and RT-PCR was done using four commercial diagnostic kits from different manufacturers, DANN and BGI (China), Hibrigen, and Bio-speedy (Turkey). Result: Although all 92 clinical samples were subjected to the same four diagnostic kits, the results revealed variations in the performance. The total number of positive cases was (42/92) for Da An Gene, BGI (36/92), Bio-speedy (31/92), and Hibrirgen (14/92).

Downloads

Download data is not yet available.

Downloads

Published

2023-05-20

How to Cite

Evaluation of four commercial COVID-19 diagnostic RT-PCR kits used in Libya. (2023). Journal of Medical Sciences, 18(1), 26-30. https://doi.org/10.51984/joms.v18i1.2600

Similar Articles

1-10 of 31

You may also start an advanced similarity search for this article.